{
    "table_name": "CPTAC.QUANT_PHOSPHOPROTEOME_AML_QUIZARTINIB_RESISTANCE_PDC_CURRENT",
    "table_fullname": "CPTAC_PDC.CPTAC.QUANT_PHOSPHOPROTEOME_AML_QUIZARTINIB_RESISTANCE_PDC_CURRENT",
    "column_names": [
        "study_name",
        "aliquot_submitter_id",
        "case_id",
        "phosphorylation_sites",
        "aliquot_id",
        "sample_id",
        "refseq_id",
        "protein_abundance_log2ratio",
        "aliquot_run_metadata_id"
    ],
    "column_types": [
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "FLOAT",
        "TEXT"
    ],
    "description": [
        null,
        null,
        null,
        null,
        null,
        null,
        null,
        null,
        null
    ],
    "sample_rows": [
        {
            "case_id": "4a4b2172-550c-4dbd-adad-8b3425f3ddea",
            "sample_id": "baf671ff-e1b6-4cd9-9dfd-5d263db4f5df",
            "aliquot_id": "8dc69c53-9a45-4b6d-a3c1-4f3637f26440",
            "aliquot_submitter_id": "PTRC_exp12_P5-1",
            "aliquot_run_metadata_id": "dfdf5e29-db86-48bd-83e9-009e078627ea",
            "study_name": "AML Quizartinib Resistance -  Phosphoproteome",
            "protein_abundance_log2ratio": -0.3275,
            "refseq_id": "NP_001008697.1",
            "phosphorylation_sites": "s59"
        },
        {
            "case_id": "4a4b2172-550c-4dbd-adad-8b3425f3ddea",
            "sample_id": "baf671ff-e1b6-4cd9-9dfd-5d263db4f5df",
            "aliquot_id": "8dc69c53-9a45-4b6d-a3c1-4f3637f26440",
            "aliquot_submitter_id": "PTRC_exp12_P5-1",
            "aliquot_run_metadata_id": "dfdf5e29-db86-48bd-83e9-009e078627ea",
            "study_name": "AML Quizartinib Resistance -  Phosphoproteome",
            "protein_abundance_log2ratio": -0.5091,
            "refseq_id": "NP_001026850.1",
            "phosphorylation_sites": "s228"
        },
        {
            "case_id": "4a4b2172-550c-4dbd-adad-8b3425f3ddea",
            "sample_id": "baf671ff-e1b6-4cd9-9dfd-5d263db4f5df",
            "aliquot_id": "8dc69c53-9a45-4b6d-a3c1-4f3637f26440",
            "aliquot_submitter_id": "PTRC_exp12_P5-1",
            "aliquot_run_metadata_id": "dfdf5e29-db86-48bd-83e9-009e078627ea",
            "study_name": "AML Quizartinib Resistance -  Phosphoproteome",
            "protein_abundance_log2ratio": 0.317,
            "refseq_id": "NP_001092108.1",
            "phosphorylation_sites": "s693"
        },
        {
            "case_id": "4a4b2172-550c-4dbd-adad-8b3425f3ddea",
            "sample_id": "baf671ff-e1b6-4cd9-9dfd-5d263db4f5df",
            "aliquot_id": "8dc69c53-9a45-4b6d-a3c1-4f3637f26440",
            "aliquot_submitter_id": "PTRC_exp12_P5-1",
            "aliquot_run_metadata_id": "dfdf5e29-db86-48bd-83e9-009e078627ea",
            "study_name": "AML Quizartinib Resistance -  Phosphoproteome",
            "protein_abundance_log2ratio": -0.165,
            "refseq_id": "NP_001122405.1",
            "phosphorylation_sites": "s902"
        },
        {
            "case_id": "4a4b2172-550c-4dbd-adad-8b3425f3ddea",
            "sample_id": "baf671ff-e1b6-4cd9-9dfd-5d263db4f5df",
            "aliquot_id": "8dc69c53-9a45-4b6d-a3c1-4f3637f26440",
            "aliquot_submitter_id": "PTRC_exp12_P5-1",
            "aliquot_run_metadata_id": "dfdf5e29-db86-48bd-83e9-009e078627ea",
            "study_name": "AML Quizartinib Resistance -  Phosphoproteome",
            "protein_abundance_log2ratio": -0.4735,
            "refseq_id": "NP_001129333.1",
            "phosphorylation_sites": "s33"
        }
    ]
}